Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFIELD: De-intensified IMRT in Head and Neck Cancer
NCT03067610Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in oropharyngeal squamous cell carcinoma (OPSCC) and laryngeal squamous cell carcinoma (LSCC), sponsored by UT Southwestern Medical Center. Primary endpoint: Number of Patients With Solitary Elective Volume Recurrence at 2 years. Started Jan 2017; status: completed.
02
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)laryngeal squamous cell carcinoma (LSCC)
Beyond the preview
Go deeper on NCT03067610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067610.